1. Home
  2. WVE vs MQY Comparison

WVE vs MQY Comparison

Compare WVE & MQY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WVE
  • MQY
  • Stock Information
  • Founded
  • WVE 2012
  • MQY 1994
  • Country
  • WVE Singapore
  • MQY United States
  • Employees
  • WVE N/A
  • MQY N/A
  • Industry
  • WVE Biotechnology: Pharmaceutical Preparations
  • MQY Investment Bankers/Brokers/Service
  • Sector
  • WVE Health Care
  • MQY Finance
  • Exchange
  • WVE Nasdaq
  • MQY Nasdaq
  • Market Cap
  • WVE 915.6M
  • MQY 776.5M
  • IPO Year
  • WVE 2015
  • MQY N/A
  • Fundamental
  • Price
  • WVE $7.79
  • MQY $11.66
  • Analyst Decision
  • WVE Strong Buy
  • MQY
  • Analyst Count
  • WVE 16
  • MQY 0
  • Target Price
  • WVE $20.19
  • MQY N/A
  • AVG Volume (30 Days)
  • WVE 2.1M
  • MQY 184.8K
  • Earning Date
  • WVE 11-11-2025
  • MQY 01-01-0001
  • Dividend Yield
  • WVE N/A
  • MQY 4.73%
  • EPS Growth
  • WVE N/A
  • MQY N/A
  • EPS
  • WVE N/A
  • MQY N/A
  • Revenue
  • WVE $93,946,000.00
  • MQY N/A
  • Revenue This Year
  • WVE N/A
  • MQY N/A
  • Revenue Next Year
  • WVE $6.85
  • MQY N/A
  • P/E Ratio
  • WVE N/A
  • MQY N/A
  • Revenue Growth
  • WVE N/A
  • MQY N/A
  • 52 Week Low
  • WVE $5.28
  • MQY $9.82
  • 52 Week High
  • WVE $16.74
  • MQY $12.52
  • Technical
  • Relative Strength Index (RSI)
  • WVE 52.90
  • MQY 60.62
  • Support Level
  • WVE $6.91
  • MQY $11.45
  • Resistance Level
  • WVE $8.31
  • MQY $11.67
  • Average True Range (ATR)
  • WVE 0.42
  • MQY 0.10
  • MACD
  • WVE 0.15
  • MQY -0.03
  • Stochastic Oscillator
  • WVE 69.65
  • MQY 63.43

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About MQY Blackrock MuniYield Quality Fund Inc.

Blackrock Muniyield Quality Fund Inc is a closed-end management investment company. The company's objective is to provide shareholders with as high a level of current income exempt from U.S. federal income taxes as is consistent with its investment policies and prudent investment management. The company invests in Transportation, Corporate, Health, Utilities, Education, Housing, and other sectors.

Share on Social Networks: